Securities code: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) securities abbreviation: Tibet Duo Rui Pharmaceutical Co.Ltd(301075) Announcement No.: 2022020 Tibet Duo Rui Pharmaceutical Co.Ltd(301075)
Announcement on 2021 profit distribution plan
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) (hereinafter referred to as “the company”) held the 11th meeting of the first board of directors and the 9th meeting of the first board of supervisors on March 23, 2022, and deliberated and adopted the 2021 profit distribution plan. This matter shall be submitted to the 2021 annual general meeting of shareholders of the company for deliberation and approval, and shall be approved by more than two-thirds of the voting rights held by the shareholders attending the meeting. The specific situation is hereby announced as follows:
1、 Specific contents of profit distribution plan
According to the “tianjianshen [2022] No. 1158 audit report” issued by Tianjian Certified Public Accountants (special general partnership), the audited net profit attributable to the owner of the parent company in 2021 was 6850788304 yuan. Among them, the net profit realized by the parent company is 5349989979 yuan, the surplus reserve withdrawn by the parent company is 534998998 yuan, the distributable profit realized by the parent company in the current year is 4814990981 yuan, plus the undistributed profit of the company in previous years, the distributable profit of the parent company at the end of the period is 11595598172 yuan.
Following the principle of rewarding shareholders and sharing the company’s operating results with shareholders, under the condition of ensuring the healthy and sustainable development of the company and taking into account the company’s future business development needs, it is proposed that the company’s profit distribution plan for 2021 is: it is proposed to take the total share capital of the company as of December 31, 2021
Based on 80000000 shares, a cash dividend of 6.25 yuan (including tax) will be distributed to all shareholders for every 10 shares, with a total cash dividend of 50000000 yuan (including tax). The remaining undistributed profits will be carried forward to the following years. No bonus shares will be given this year, and no accumulation fund will be converted into share capital.
The share capital base of this profit distribution does not include repurchased shares. As of the disclosure date of this announcement, the company has not repurchased shares. After the board of directors deliberates the profit distribution plan and before its implementation, if the share capital of the company changes, the distribution proportion will be adjusted according to the principle that the total distribution amount remains unchanged.
2、 Legality and compliance of profit distribution plan
The profit distribution plan complies with the company law, accounting standards for business enterprises, the notice on further implementing the matters related to cash dividends of listed companies issued by the CSRC, the CSRC’s regulatory guidelines for listed companies No. 3 – cash dividends of listed companies (revised in 2022), the articles of association and other provisions, and complies with the profit distribution policy, profit distribution plan and The long-term return plan and relevant commitments made by shareholders are conducive to all shareholders to share the operating results of the company. This profit distribution plan meets the needs of the company’s future operation and development, and has legitimacy, compliance and rationality.
3、 Opinions of independent directors
In order to better repay the shareholders, the distribution plan proposed by the board of directors based on the actual situation of the company meets the requirements of the guidelines for the supervision of listed companies No. 3 – cash dividends of listed companies, the articles of association and relevant laws, regulations and rules, conforms to the interests of the company’s shareholders, meets the needs of development, and does not harm the interests of investors.
We agree to the 2021 profit distribution plan proposed by the board of directors and submit it to the 2021 annual general meeting of shareholders of the company for deliberation.
4、 Other
The profit distribution plan can only be implemented after being reviewed and approved by the company’s 2021 annual general meeting of shareholders. Please pay attention to the investment risks.
5、 Documents for future reference
(I) resolutions of the 11th meeting of the first board of directors of the company
(II) resolutions of the ninth meeting of the first board of supervisors of the company
(III) independent opinions of independent directors on matters related to the 11th meeting of the first board of directors
It is hereby announced.
Tibet Duo Rui Pharmaceutical Co.Ltd(301075) board of directors March 24, 2022
